| |
Molecular and Cellular Oncogenesis
The overall goal of the Molecular and Cellular
Oncogenesis Program is to understand normal and malignant cell growth
and differentiation. The program consists of two synergistic research
divisions. The Cancer Biology Division focuses on the roles
of specific signaling pathways, oncogenes, growth factors, and the
cellular microenvironment on tumor development and progression.
A major objective is to better understand the biological impact
of specific molecular events associated with tumor formation and
the progression toward metastatic disease. The Systems
Biology Division has a long-term goal of developing
global perspectives of how specific molecular events implicated
in tumor development and progression are manifested at the level
of the cell, tissue and interacting systems in the organism. Member
laboratories are studying large protein complexes and cellular machines,
how cellular networks respond to different signaling pathways, and
changes in global patterns of gene expression at the genetic and
protein levels influence normal and disease processes. Current and
emerging investigative strategies and disciplines that are particularly
critical for systems analyses of human diseases include nucleotide
microarrays, proteomics, computational biology, and functional genomics..
Cancer Biology Division
Anthony
Capobianco, Ph.D.
Nadia Dahmane, Ph.D.
Dorothee Herlyn, D.V.M., D.Sc.
Thanos Halazonetis, D.D.S., Ph.D.
Meenhard Herlyn, D.V.M., D.Sc.*
Russel Kaufman,
M.D.
Joseph Kissil, Ph.D.
|
|
Systems Biology
Division
Ellen
Heber-Katz, Ph.D.
Qihong Huang, M.D., Ph.D.
Carlo C. Maley, Ph.D.
Ellen Puré, Ph.D.
Harold C. Riethman, Ph.D.
Ramin Shiekhattar, Ph.D.
Louise C. Showe, Ph.D.
David W. Speicher, Ph.D.
** |
| |
|
|
*
Denotes program leader & division leader **
Denotes program co-leader & division leader |
|
|